[34] Use of fusions to viral coat proteins as antigenic carriers for vaccine development
References (47)
Vaccine
(1999)- et al.
J. Mol. Biol.
(1993) Arch. Biochem. Biophys.
(1997)Gene
(1983)- et al.
Prog. Nucleic Acids Mol. Biol.
(1990) - et al.
Anal. Biochem.
(1987) J. Mol. Biol.
(1967)- et al.
Arch. Biochem. Biophys.
(1969) - et al.
Methods Enzymol.
(1989) J. Chromotogr.
(1991)
J. Immunol. Methods
(1988)
Tib. Tech.
(1991)
Hum. Immunol.
(1996)
Immunochemistry
(1971)
J. Immunol. Methods
(1987)
Science
(1986)
J. Virol.
(1998)
Science
(1990)
Annu. Rev. Biochem.
(1990)
Science
(1996)
Nature
(1996)
Annu. Rev. Biochem.
(1989)
Pepscan to Determine T and B Cell Epitopes
(1995)
Cited by (9)
Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
2008, Journal of Molecular BiologyQuantification of RNA in bacteriophage MS2-like viruses in solution by small-angle X-ray scattering
2006, Radiation Physics and ChemistrySelective in Situ Assembly of Viral Protein onto DNA Origami
2018, Journal of the American Chemical SocietyThe true story and advantages of RNA phage capsids as nanotools
2016, IntervirologyBacteriophage virus-like particles as a platform for vaccine discovery
2015, Viral Nanotechnology
Copyright © 2000 Published by Elsevier Inc.